CLINICAL_TRIALS
trial_result
· 2024-02-28
Clinical Trial Update: A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013) [Phase 2]
Summary
Phase 2 study of belzutifan (MK-6482) in participants with advanced renal cell carcinoma; results have been posted and the trial is currently active but not rec…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-02-28